Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 501

1.

Sensor-Based Upper-Extremity Frailty Assessment for the Vascular Surgery Risk Stratification.

Yanquez FJ, Peterson A, Weinkauf C, Goshima KR, Zhou W, Mohler J, Ehsani H, Toosizadeh N.

J Surg Res. 2019 Oct 17. pii: S0022-4804(19)30663-8. doi: 10.1016/j.jss.2019.09.029. [Epub ahead of print]

PMID:
31630882
2.

Current recommendations for prostate cancer genetic testing: NCCN prostate guideline.

Mohler JL, Higano CS, Schaeffer EM, Cheng HH.

Can J Urol. 2019 Oct;26(5S2):34-37.

3.

Screening older adults for amnestic mild cognitive impairment and early-stage Alzheimer's disease using upper-extremity dual-tasking.

Toosizadeh N, Ehsani H, Wendel C, Zamrini E, Connor KO, Mohler J.

Sci Rep. 2019 Jul 29;9(1):10911. doi: 10.1038/s41598-019-46925-y.

4.

Prevalence and predictors of probable depression in prostate cancer survivors.

Erim DO, Bensen JT, Mohler JL, Fontham ETH, Song L, Farnan L, Delacroix SE, Peters ES, Erim TN, Chen RC, Gaynes BN.

Cancer. 2019 Oct 1;125(19):3418-3427. doi: 10.1002/cncr.32338. Epub 2019 Jun 27.

PMID:
31246284
5.

Proximity-Induced Bioorthogonal Chemistry Using Inverse Electron Demand Diels-Alder Reaction.

Möhler JS, Werther P, Wombacher R.

Methods Mol Biol. 2019;2008:147-163. doi: 10.1007/978-1-4939-9537-0_12.

PMID:
31124095
6.

NCCN Guidelines Updates: Management of Prostate Cancer.

Mohler JL, Antonarakis ES.

J Natl Compr Canc Netw. 2019 May 1;17(5.5):583-586. doi: 10.6004/jnccn.2019.5011.

PMID:
31117038
7.

Patterns and predictors of self-reported clinical diagnosis and treatment for depression in prostate cancer survivors.

Erim DO, Bensen JT, Mohler JL, Fontham ETH, Song L, Farnan L, Delacroix SE, Peters ES, Erim TN, Chen RC, Gaynes BN.

Cancer Med. 2019 Jul;8(8):3648-3658. doi: 10.1002/cam4.2239. Epub 2019 May 20.

8.

Wake up call for collegiate athlete sleep: narrative review and consensus recommendations from the NCAA Interassociation Task Force on Sleep and Wellness.

Kroshus E, Wagner J, Wyrick D, Athey A, Bell L, Benjamin HJ, Grandner MA, Kline CE, Mohler JM, Roxanne Prichard J, Watson NF, Hainline B.

Br J Sports Med. 2019 Jun;53(12):731-736. doi: 10.1136/bjsports-2019-100590. Epub 2019 May 16. Review.

PMID:
31097460
9.

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Mohler JL, Antonarakis ES, Armstrong AJ, D'Amico AV, Davis BJ, Dorff T, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Ippolito JE, Kane CJ, Kuettel MR, Lang JM, McKenney J, Netto G, Penson DF, Plimack ER, Pow-Sang JM, Pugh TJ, Richey S, Roach M, Rosenfeld S, Schaeffer E, Shabsigh A, Small EJ, Spratt DE, Srinivas S, Tward J, Shead DA, Freedman-Cass DA.

J Natl Compr Canc Netw. 2019 May 1;17(5):479-505. doi: 10.6004/jnccn.2019.0023.

PMID:
31085757
10.

Association among plasma 1,25(OH)2 D, ratio of 1,25(OH)2 D to 25(OH)D, and prostate cancer aggressiveness.

Ramakrishnan S, Steck SE, Arab L, Zhang H, Bensen JT, Fontham ETH, Johnson CS, Mohler JL, Smith GJ, Su LJ, Woloszynska A.

Prostate. 2019 Jul;79(10):1117-1124. doi: 10.1002/pros.23824. Epub 2019 May 11.

11.

Potential impact of combined inhibition of 3α-oxidoreductases and 5α-reductases on prostate cancer.

Fiandalo MV, Gewirth DT, Mohler JL.

Asian J Urol. 2019 Jan;6(1):50-56. doi: 10.1016/j.ajur.2018.09.002. Epub 2018 Sep 26. Review.

12.

In honor of Dr. Donald S. Coffey - Prostate cancer biology and therapy.

Gao AC, Mohler JL.

Asian J Urol. 2019 Jan;6(1):1-2. doi: 10.1016/j.ajur.2018.10.002. Epub 2018 Nov 3. No abstract available.

13.

Cytochrome c Deficiency Confers Apoptosome and Mitochondrial Dysfunction in African-American Men with Prostate Cancer.

Kumar R, Bhat TA, Walsh EM, Chaudhary AK, O'Malley J, Rhim JS, Wang J, Morrison CD, Attwood K, Bshara W, Mohler JL, Yadav N, Chandra D.

Cancer Res. 2019 Apr 1;79(7):1353-1368. doi: 10.1158/0008-5472.CAN-18-2383. Epub 2019 Feb 14.

PMID:
30765600
14.

Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.

Venkadakrishnan VB, DePriest AD, Kumari S, Senapati D, Ben-Salem S, Su Y, Mudduluru G, Hu Q, Cortes E, Pop E, Mohler JL, Azabdaftari G, Attwood K, Shah RB, Jamieson C, Dehm SM, Magi-Galluzzi C, Klein E, Sharifi N, Liu S, Heemers HV.

Oncogene. 2019 Jun;38(23):4496-4511. doi: 10.1038/s41388-019-0732-7. Epub 2019 Feb 11.

15.

Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance.

Kim HL, Li P, Huang HC, Deheshi S, Marti T, Knudsen B, Abou-Ouf H, Alam R, Lotan TL, Lam LLC, du Plessis M, Davicioni E, Fleshner N, Lane BR, Ross AE, Davis JW, Mohler JL, Trock BJ, Klein EA, Tosoian JJ, Hyndman ME, Bismar TA.

Prostate Cancer Prostatic Dis. 2019 Sep;22(3):399-405. doi: 10.1038/s41391-018-0101-6. Epub 2018 Dec 12.

16.

A Festschrift in Honor of Edward M. Messing, MD, FACS.

Joseph JV, Brasacchio R, Fung C, Reeder J, Bylund K, Sahasrabudhe D, Yeh SY, Ghazi A, Fultz P, Rubens D, Wu G, Singer E, Schwarz E, Mohile S, Mohler J, Theodorescu D, Lee YF, Okunieff P, McConkey D, Rashid H, Chang C, Fradet Y, Guru K, Kukreja J, Sufrin G, Lotan Y, Bailey H, Noyes K, Schwartz S, Rideout K, Bratslavsky G, Campbell SC, Derweesh I, Abrahamsson PA, Soloway M, Gomella L, Golijanin D, Svatek R, Frye T, Lerner S, Palapattu G, Wilding G, Droller M, Trump D.

Bladder Cancer. 2018 Oct 3;4(Suppl 1):S1-S43. doi: 10.3233/BLC-189037. No abstract available.

17.

Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series.

Mohler JL, Halabi S, Ryan ST, Al-Daghmin A, Sokoloff MH, Steinberg GD, Sanford BL, Eastham JA, Walther PJ, Morris MJ, Small EJ.

Prostate Cancer Prostatic Dis. 2019 May;22(2):309-316. doi: 10.1038/s41391-018-0106-1. Epub 2018 Nov 1.

18.

Dietary patterns based on the Mediterranean diet and DASH diet are inversely associated with high aggressive prostate cancer in PCaP.

Schneider L, Su LJ, Arab L, Bensen JT, Farnan L, Fontham ETH, Song L, Hussey J, Merchant AT, Mohler JL, Steck SE.

Ann Epidemiol. 2019 Jan;29:16-22.e1. doi: 10.1016/j.annepidem.2018.08.012. Epub 2018 Sep 5.

PMID:
30268488
19.

The association of metformin use with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.

Khan S, Cai J, Nielsen ME, Troester MA, Mohler JL, Fontham ETH, Farnan L, Drake BF, Olshan AF, Bensen JT.

Cancer Causes Control. 2018 Nov;29(11):1143-1150. doi: 10.1007/s10552-018-1087-z. Epub 2018 Sep 28.

20.

The Effect of Pain Relief on Daily Physical Activity: In-Home Objective Physical Activity Assessment in Chronic Low Back Pain Patients after Paravertebral Spinal Block.

Chuan Yen T, Mohler J, Dohm M, Laksari K, Najafi B, Toosizadeh N.

Sensors (Basel). 2018 Sep 12;18(9). pii: E3048. doi: 10.3390/s18093048.

21.

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses.

Li Q, Deng Q, Chao HP, Liu X, Lu Y, Lin K, Liu B, Tang GW, Zhang D, Tracz A, Jeter C, Rycaj K, Calhoun-Davis T, Huang J, Rubin MA, Beltran H, Shen J, Chatta G, Puzanov I, Mohler JL, Wang J, Zhao R, Kirk J, Chen X, Tang DG.

Nat Commun. 2018 Sep 6;9(1):3600. doi: 10.1038/s41467-018-06067-7.

22.

Frailty Syndrome, Cognition, and Dysphonia in the Elderly.

Samlan RA, Black MA, Abidov M, Mohler J, Fain M.

J Voice. 2018 Jul 25. pii: S0892-1997(18)30196-6. doi: 10.1016/j.jvoice.2018.06.001. [Epub ahead of print]

PMID:
30055984
23.

Proteomic Analysis of Charcoal-Stripped Fetal Bovine Serum Reveals Changes in the Insulin-like Growth Factor Signaling Pathway.

Tu C, Fiandalo MV, Pop E, Stocking JJ, Azabdaftari G, Li J, Wei H, Ma D, Qu J, Mohler JL, Tang L, Wu Y.

J Proteome Res. 2018 Sep 7;17(9):2963-2977. doi: 10.1021/acs.jproteome.8b00135. Epub 2018 Aug 3.

PMID:
30014700
24.

Mathematical modeling of intracrine androgen metabolism in prostate cancer: Methodological aspects.

Cook SF, Fiandalo MV, Watt DS, Wu Y, Mohler JL, Bies RR.

Prostate. 2018 Jun 25. doi: 10.1002/pros.23665. [Epub ahead of print]

PMID:
29938815
25.

Modelling attrition and nonparticipation in a longitudinal study of prostate cancer.

Spiers S, Oral E, Fontham ETH, Peters ES, Mohler JL, Bensen JT, Brennan CS.

BMC Med Res Methodol. 2018 Jun 20;18(1):60. doi: 10.1186/s12874-018-0518-6.

26.

Silver bullets: A new lustre on an old antimicrobial agent.

Möhler JS, Sim W, Blaskovich MAT, Cooper MA, Ziora ZM.

Biotechnol Adv. 2018 Sep - Oct;36(5):1391-1411. doi: 10.1016/j.biotechadv.2018.05.004. Epub 2018 May 27. Review.

PMID:
29847770
27.

Frailty Assessment Predicts Acute Outcomes in Patients Undergoing Screening Colonoscopy.

Taleban S, Toosizadeh N, Junna S, Golden T, Ghazala S, Wadeea R, Tirambulo C, Mohler J.

Dig Dis Sci. 2018 Dec;63(12):3272-3280. doi: 10.1007/s10620-018-5129-x. Epub 2018 May 24.

PMID:
29796910
28.

NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.

Carroll PH, Mohler JL.

J Natl Compr Canc Netw. 2018 May;16(5S):620-623. doi: 10.6004/jnccn.2018.0036.

PMID:
29784740
29.

Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina-Louisiana Prostate Cancer Project (PCaP).

Steck SE, Omofuma OO, Su LJ, Maise AA, Woloszynska-Read A, Johnson CS, Zhang H, Bensen JT, Fontham ETH, Mohler JL, Arab L.

Am J Clin Nutr. 2018 May 1;107(5):799-807. doi: 10.1093/ajcn/nqy037.

PMID:
29722851
30.

Statin use, high cholesterol and prostate cancer progression; results from HCaP-NC.

Allott EH, Farnan L, Steck SE, Song L, Arab L, Su LJ, Fontham ETH, Mohler JL, Bensen JT.

Prostate. 2018 Aug;78(11):857-864. doi: 10.1002/pros.23644. Epub 2018 May 1.

PMID:
29717502
31.

Proprioceptive impairments in high fall risk older adults: the effect of mechanical calf vibration on postural balance.

Toosizadeh N, Ehsani H, Miramonte M, Mohler J.

Biomed Eng Online. 2018 May 2;17(1):51. doi: 10.1186/s12938-018-0482-8.

32.

A brief history of intracrine androgen metabolism by castration-recurrent prostate cancer.

Mohler JL.

Am J Clin Exp Urol. 2018 Apr 1;6(2):101-106. eCollection 2018. Review.

33.

An assisted living interprofessional education and practice geriatric screening clinic (IPEP-GSC): a description and evaluation.

Lee J, Cioltan H, Goldsmith P, Heasley B, Dermody M, Fain M, Mohler J.

Gerontol Geriatr Educ. 2018 Apr 13:1-12. doi: 10.1080/02701960.2018.1463222. [Epub ahead of print]

PMID:
29652611
34.

Development of a Patient-Based Model for Estimating Operative Times for Robot-Assisted Radical Prostatectomy.

Huben NB, Hussein AA, May PR, Whittum M, Krasowski C, Ahmed YE, Jing Z, Khan H, Kim HL, Schwaab T, Underwood W, Kauffman EC, Mohler JL, Guru KA.

J Endourol. 2018 Aug;32(8):730-736. doi: 10.1089/end.2018.0249.

35.

Low intensity vibration of ankle muscles improves balance in elderly persons at high risk of falling.

Toosizadeh N, Mohler J, Marlinski V.

PLoS One. 2018 Mar 26;13(3):e0194720. doi: 10.1371/journal.pone.0194720. eCollection 2018.

36.

Inhibition of dihydrotestosterone synthesis in prostate cancer by combined frontdoor and backdoor pathway blockade.

Fiandalo MV, Stocking JJ, Pop EA, Wilton JH, Mantione KM, Li Y, Attwood KM, Azabdaftari G, Wu Y, Watt DS, Wilson EM, Mohler JL.

Oncotarget. 2018 Jan 10;9(13):11227-11242. doi: 10.18632/oncotarget.24107. eCollection 2018 Feb 16.

37.

The influence of mechanical vibration on local and central balance control.

Ehsani H, Mohler J, Marlinski V, Rashedi E, Toosizadeh N.

J Biomech. 2018 Apr 11;71:59-66. doi: 10.1016/j.jbiomech.2018.01.027. Epub 2018 Feb 3.

PMID:
29459070
38.

Serum-free complete medium, an alternative medium to mimic androgen deprivation in human prostate cancer cell line models.

Fiandalo MV, Wilton JH, Mantione KM, Wrzosek C, Attwood KM, Wu Y, Mohler JL.

Prostate. 2018 Feb;78(3):213-221. doi: 10.1002/pros.23459. Epub 2017 Dec 1.

39.

Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.

Conti DV, Wang K, Sheng X, Bensen JT, Hazelett DJ, Cook MB, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Sanderson M, John EM, Park JY, Xu J, Stevens VL, Berndt SI, Huff CD, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Sellers TA, Yamoah K, Murphy AB, Crawford DC, Gapstur SM, Bush WS, Aldrich MC, Cussenot O, Petrovics G, Cullen J, Neslund-Dudas C, Stern MC, Jarai ZK, Govindasami K, Chokkalingam AP, Hsing AW, Goodman PJ, Hoffmann T, Drake BF, Hu JJ, Clark PE, Van Den Eeden SK, Blanchet P, Fowke JH, Casey G, Hennis AJM, Han Y, Lubwama A, Thompson IM Jr, Leach R, Easton DF, Schumacher F, Van den Berg DJ, Gundell SM, Stram A, Wan P, Xia L, Pooler LC, Mohler JL, Fontham ETH, Smith GJ, Taylor JA, Srivastava S, Eeles RA, Carpten J, Kibel AS, Multigner L, Parent ME, Menegaux F, Cancel-Tassin G, Klein EA, Brureau L, Stram DO, Watya S, Chanock SJ, Witte JS, Blot WJ, Henderson BE, Haiman CA; PRACTICAL/ELLIPSE Consortium.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx084.

40.

A Bifunctional Fluorogenic Rhodamine Probe for Proximity-Induced Bioorthogonal Chemistry.

Werther P, Möhler JS, Wombacher R.

Chemistry. 2017 Dec 22;23(72):18216-18224. doi: 10.1002/chem.201703607. Epub 2017 Nov 28.

PMID:
29044851
41.
42.

Developing antineoplastic agents that target peroxisomal enzymes: cytisine-linked isoflavonoids as inhibitors of hydroxysteroid 17-beta-dehydrogenase-4 (HSD17B4).

Frasinyuk MS, Zhang W, Wyrebek P, Yu T, Xu X, Sviripa VM, Bondarenko SP, Xie Y, Ngo HX, Morris AJ, Mohler JL, Fiandalo MV, Watt DS, Liu C.

Org Biomol Chem. 2017 Sep 20;15(36):7623-7629. doi: 10.1039/c7ob01584d.

43.

Foot Problems in Older Adults Associations with Incident Falls, Frailty Syndrome, and Sensor-Derived Gait, Balance, and Physical Activity Measures.

Muchna A, Najafi B, Wendel CS, Schwenk M, Armstrong DG, Mohler J.

J Am Podiatr Med Assoc. 2018 Mar;108(2):126-139. doi: 10.7547/15-186. Epub 2017 Aug 30.

44.

Frailty assessment in older adults using upper-extremity function: index development.

Toosizadeh N, Wendel C, Hsu CH, Zamrini E, Mohler J.

BMC Geriatr. 2017 Jun 2;17(1):117. doi: 10.1186/s12877-017-0509-1.

45.

Blinded review of archival radical prostatectomy specimens supports that contemporary Gleason score 6 prostate cancer lacks metastatic potential.

Nunez Bragayrac LA, Murekeyisoni C, Vacchio MJ, Attwood K, Mehedint DC, Mohler JL, Azabdaftari G, Xu B, Kauffman EC.

Prostate. 2017 Jul;77(10):1076-1081. doi: 10.1002/pros.23364. Epub 2017 May 26.

PMID:
28547760
46.

Sensor-based balance training with motion feedback in people with mild cognitive impairment.

Schwenk M, Sabbagh M, Lin I, Morgan P, Grewal GS, Mohler J, Coon DW, Najafi B.

J Rehabil Res Dev. 2016;53(6):945-958. doi: 10.1682/JRRD.2015.05.0089.

47.

Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer.

Parsons JK, Pierce JP, Mohler J, Paskett E, Jung SH, Morris MJ, Small E, Hahn O, Humphrey P, Taylor J, Marshall J.

BJU Int. 2018 Apr;121(4):534-539. doi: 10.1111/bju.13890. Epub 2017 May 21.

48.

Lipid degradation promotes prostate cancer cell survival.

Itkonen HM, Brown M, Urbanucci A, Tredwell G, Ho Lau C, Barfeld S, Hart C, Guldvik IJ, Takhar M, Heemers HV, Erho N, Bloch K, Davicioni E, Derua R, Waelkens E, Mohler JL, Clarke N, Swinnen JV, Keun HC, Rekvig OP, Mills IG.

Oncotarget. 2017 Jun 13;8(24):38264-38275. doi: 10.18632/oncotarget.16123.

49.

Tobacco use and outcome in radical prostatectomy patients.

Curtis A, Ondracek RP, Murekeyisoni C, Kauffman E, Mohler J, Marshall J.

Cancer Med. 2017 Apr;6(4):857-864. doi: 10.1002/cam4.1041. Epub 2017 Mar 20.

50.

Postural Transitions during Activities of Daily Living Could Identify Frailty Status: Application of Wearable Technology to Identify Frailty during Unsupervised Condition.

Parvaneh S, Mohler J, Toosizadeh N, Grewal GS, Najafi B.

Gerontology. 2017;63(5):479-487. doi: 10.1159/000460292. Epub 2017 Mar 11.

Supplemental Content

Loading ...
Support Center